Home Tags NICE


To Reimburse or not to Reimburse – That is the Question

Novel, innovative (bio)pharmaceutical drugs are an important part of our global healthcare system, offering advanced, radical new personalized and targeted therapy options to patients...

Growing Drug Development Outsourcing Expected to Increase Demand for Antibody-drug Conjugates

A recent research report published by Technavio, a leading global technology research and advisory company, confirms that the global antibody-drug conjugates (ADC) market will grow...